Search

everythinglearnresearchcommunity

for

Search:↓

Almost 40% of women aged 20-70 in Isfahan had hair loss, with it being more severe in those with low ferritin levels.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Vitamins and minerals don't significantly affect hair loss treatment in patients with telogen effluvium.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

A nutrition program improved a young woman's concussion symptoms.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.

Premature graying of hair is linked to various health issues and can sometimes be reversed by treating underlying conditions.

Low vitamin D and ferritin levels are linked to female hair loss.

Low ferritin levels might be linked to telogen effluvium, but vitamin D levels are not.

No significant difference in iron deficiency between women with or without hair loss.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Iron deficiency might contribute to hair loss in women.

Researchers made minoxidil efficiently using cobalt ferrite nanoparticles as a reusable catalyst.

Iron deficiency is linked to hair loss in CTE patients.

Ayurvedic medicine helped increase a young woman's hemoglobin levels and improved her anemia symptoms.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Thyroid function may influence hair loss after COVID-19.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Microneedle made of iron oxide and PVA helps hair regrowth in alopecia treatment.